COLLABORATE WITH EADB
EADB makes publicly available key summary statistics published in articles
- GWAS on AD risk including UK biobank AD-proxy data
(Link to summary statistics : Bellenguez et al, Nat Genet, 2022) - GWAS on tau, p-tau and Ab42 levels
(Link to summary statistics : Jensen et al, Acta Neuropathol, 2023) - Rare variant burden test results
(Link to summary statistics : Holstege et al, Nat Genet, 2022). - XWAS on AD risk including UK biobank AD-proxy data
(Link to summary statistics : Leborgne et al, Mol Psychiatry, 2024).
Access to additional summary statistics or raw data for specific analyses is available through collaboration, see how to apply below.
Your request
Access to raw data or non-publicly
summary statistics are encouraged
through collaboration.
Evaluation by the EADB steering committee
The projects will be evaluated by the EADB steering committee to define:
- scientific relevance
- potential overlap with other ongoing EADB projects (potential collaboration could be proposed)
- priority and feasability
Rules
- A synopsis describing the project has
to be communicated (see below) - a EADB banner will be systematically
added in the author list. In function of
the project, co-authorship can be required (case-by-case discussion) - EADB JPND funding will be
acknowledged
Specific request
In the case of specific requests (not manageable with the form below), please contact:
jean-charles.lambert@pasteur-lille.fr
COLLABORATE
COLLABORATE WITH US
Fill the form below to contact us
If you are a company, sponsor or association and would like to support research on Alzheimer’s disease, please contact us. We will be happy to discuss funding opportunities with you.
COLLABORATE ON SEQUENCING
Sequencing data are available for collaboration and after approval by the EADB Steering Committee, at the Genetics Hub. This hub brings the sequencing data together in a secure environment for analysis.
